You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》上證半日平收 深成創板微升 券商及醫藥生物股造高
內地昨日(2日)新增確診病例90例。人民幣中間價上調50點。上證深成低開後反覆靠穩。 上證半日平收報3,464點;深成指升6點或0.04%,收報14,804點;滬深300指數升11點或0.2%,報4,945點;創業板指數升7點或0.2%,收報3,501點,成交2,459億元。上證深成半日成交分別爲3,751億元及5,087億元。 中資金融股續軟,工行(601398.SH)及建行(601939.SH)分別跌0.7%及0.9%。 券商股造高,東方證券(600958.SH)漲停,國聯證券(601456.SH)及中原證券(601375.SH)分別揚9.3%及6.4%。 醫藥生物股走高,常山醫藥(300255.SZ)及賽升藥業(300485.SZ)漲停。海特生物(300683.SZ)揚6.8%。 億緯鋰能(300014.SH)高開低走,半日股價跌2%,公司擬與恩捷股份合作開展鋰離子電池隔離膜和塗布膜的製造,項目計劃投資總額爲52億元。 深圳燃氣(601139.SH)漲停,公司擬18億元收購東方日升旗下光伏膠膜供應商斯威克控股權。(ta/a) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account